Royal Bank Of Canada reiterated their outperform rating on shares of Concordia Healthcare Corp (TSE:CXR) in a research report sent to investors on Monday morning, StockTargetPrices.com reports. They currently have a C$18.00 price objective on the stock.
Several other brokerages also recently weighed in on CXR. TD Securities decreased their target price on shares of Concordia Healthcare Corp from C$45.00 to C$37.00 and set a buy rating for the company in a research note on Tuesday, June 28th. Goldman Sachs Group Inc. set a C$34.00 target price on shares of Concordia Healthcare Corp in a research note on Friday, July 22nd. Finally, CIBC downgraded shares of Concordia Healthcare Corp from a sector perform rating to an underperform rating in a research note on Monday, August 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. The company has an average rating of Hold and a consensus target price of C$27.25.
Shares of Concordia Healthcare Corp (TSE:CXR) opened at 5.99 on Monday. Concordia Healthcare Corp has a one year low of $5.80 and a one year high of $60.55. The stock has a 50 day moving average of $9.99 and a 200 day moving average of $26.43. The stock’s market cap is $305.59 million.
Concordia Healthcare Corp Company Profile
Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with MarketBeat.com's FREE daily email newsletter.